The Efficacy of Spironolactone in Patients With Resistant Hypertension

NCT00430794 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

OTHER

Sponsor class

Stopped Difficulties with recruitment.

Conditions

Hypertension

Interventions

DRUG: Spironolactone

Sponsor

Sheffield Teaching Hospitals NHS Foundation Trust

Collaborators

[object Object]